1 completed, 1 suspended. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Suspended 1 |
| Phase 2 | 2 | Completed 1, Suspended 1 |
Follow ASN-002: new trials by email Literature Review of ASN-002 trials Research Report on ASN-002
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of ASN-002 to Treat Basal Cell Carcinomas (BCCs) in Individuals With Basal Cell Nevus Syndrome (BCNS) ASN-002 - Basal Cell Carcinoma in Basal Cell Nevus Syndrome | Phase 1 / Phase 2 | Suspended | Ascend Biopharmaceuticals Ltd | 24 | 2017-12-01 | 2023-02-06 |
| A Study of the Efficacy and Safety of ASN-002 in Adult Patients With Low-risk Nodular Basal Cell Carcinoma ASN-002, 5-FU - Basal Cell Nevus Syndrome, Skin Neoplasm | Phase 1 / Phase 2 | Completed | Ascend Biopharmaceuticals Ltd | 16 | 2015-09-01 | 2018-06-06 |
Basal Cell Nevus Syndrome (2) · Carcinoma, Basal Cell (1) · Skin Neoplasms (1)
Ascend Biopharmaceuticals Ltd (2)
Australia (1) · United States (1)
Anna Bar (1) · Clement Leong (1) · Gregory Siller (1) · Lynda Spelman (1) · Rodney Sinclair (1)